Similar articles

• Letter by Potter and Le Lorier regarding article, "Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome".

  Potter BJ, Le Lorier J. Potter BJ, et al. Circulation. 2010 Aug 3;122(5):e414; author reply e415. doi: 10.1161/CIRCULATIONAHA.110.939991. Circulation. 2010. PMID: 20679578 No abstract available.
• Double-dose clopidogrel in patients undergoing PCI for ACS.

  Vassiliou V. Vassiliou V. Lancet. 2011 Jan 22;377(9762):297; author reply 298. doi: 10.1016/S0140-6736(11)60088-3. Lancet. 2011. PMID: 21256377 No abstract available.
• Prasugrel versus clopidogrel.

  Pasceri V, Patti G, Di Sciascio G. Pasceri V, et al. N Engl J Med. 2008 Mar 20;358(12):1298-9; author reply 1299-301. N Engl J Med. 2008. PMID: 18357638 No abstract available.
• Controversy of proton pump inhibitor and clopidogrel interaction: a review.

  Tan HJ. Tan HJ. J Dig Dis. 2010 Dec;11(6):334-42. doi: 10.1111/j.1751-2980.2010.00466.x. J Dig Dis. 2010. PMID: 21091895 Review.
• Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.

  Tanguay JF, Bell AD, Ackman ML, Bauer RD, Cartier R, Chan WS, Douketis J, Roussin A, Schnell G, Verma S, Wong G, Mehta SR; Canadian Cardiovascular Society. Tanguay JF, et al. Can J Cardiol. 2013 Nov;29(11):1334-45. doi: 10.1016/j.cjca.2013.07.001. Epub 2013 Aug 23. Can J Cardiol. 2013. PMID: 23978596 Review.